Nouscom

Developer of viral-vector-based vaccines for the treatment of cancer

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2015 groups37 employees language nouscom.com

Social engagement

Social engagement: 16.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Andera Partners, Bpifrance, M Ventures, Abingworth.

Investor typeCountShare
Venture capital862%
Private equity323%
Bank & private debt18%
Other / undisclosed18%

Recent activity

1 Jun 2026
Milestone
FDA
16 Jan 2026
Milestone
regulatory
Coming soon